Presenilins as therapeutic targets for the treatment of Alzheimer's disease

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.7, Iss.6, 2001-06, pp. : 264-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secretases as targets for the treatment of Alzheimer's disease

By Citron M.

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Therapeutic Targets in Allergic Eye Disease

By Bielory Leonard

Allergy and Asthma Proceedings, Vol. 22, Iss. 1, 2001-01 ,pp. : 25-28

OceanSide Publications, Inc

Access to resources Recommend Favorite

Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease

Current Molecular Medicine, Vol. 3, Iss. 5, 2003-08 ,pp. : 447-458

Bentham Science Publishers

Access to resources Recommend Favorite

A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimer's Disease

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Distinct Functions of cis and trans Phosphorylated Tau in Alzheimer's Disease and their Therapeutic Implications

Current Molecular Medicine, Vol. 13, Iss. 7, 2013-08 ,pp. : 1098-1109

Bentham Science Publishers

Access to resources Recommend Favorite